Levinson And Laliotis Mds is categorized under Doctors in San Diego, CA and active since 2010.
Levinson And Laliotis Mds was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Aristotelis T Laliotis at the company’s single location by writing to 4282 Genesee Avenue # 102, San Diego, California CA 92117 or by phoning (858) 430-1651. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Levinson And Laliotis Mds |
Contact Person: | Aristotelis T Laliotis |
Address: | 4282 Genesee Avenue # 102, San Diego, California 92117 |
Phone Number: | (858) 430-1651 |
Website Address: | balboamedicalgroup.com |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Doctors |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Levinson And Laliotis Mds was started in 2010 to provide professional Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Aristotelis T Laliotis for inquiries that concern Levinson And Laliotis Mds by calling the company number (858) 430-1651, as your correspondence is most welcome. Additionally, the physical location of the single location of Levinson And Laliotis Mds can be found at the coordinates 32.820905,-117.183003 as well as the street address 4282 Genesee Avenue # 102 in San Diego, California 92117.
For its online presence, you may visit Levinson And Laliotis Mds’s website at balboamedicalgroup.com and engage with its social media outlets through on Twitter and on Facebook.